Expertise in
5
conditions

Dr. David M. Huffman

Endocrinology
David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, 
Chattanooga, TN 
Accepting New Patients
Offers Telehealth
44 Years of Experience
Referral required
Before you request
Expertise in
5
conditions
David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, 
Chattanooga, TN 

Overview

David Huffman is an Endocrinologist practicing medicine in Chattanooga, Tennessee. He has been practicing medicine for over 44 years.

Dr. Huffman is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Hashimoto Thyroiditis, Type 2 Diabetes (T2D), and Obesity in Children.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 9 clinical trials. Dr. Huffman is currently accepting new patients.

Graduate Year

1982

Specialties

Endocrinology

Licenses

Internal Medicine in TN

Hospital Affiliations

Memorial Healthcare System, Inc
Erlanger Medical Center
Hamilton Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 25 Less Insurance Carriers -

Locations

David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, Chattanooga, TN 37411

Additional Areas of Focus

Dr. Huffman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: June 30, 2026
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Enrollment Status: Completed
Publish Date: December 22, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

6 Total Publications

Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: February 14, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Ana Cornea
Endocrinology
Expertise in
28
conditions
Dr. Ana Cornea
Endocrinology
Referral required
Before you request
979 E 3rd St, Suite 550, 
Chattanooga, TN 
 (4.9 miles away)
423-778-8224
Languages Spoken:
English, Romanian
See accepted insurances
Accepting New Patients

Ana Cornea is an Endocrinologist practicing medicine in Chattanooga, Tennessee. Dr. Cornea is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Thyroid Nodule, Hypothyroidism, Obesity in Children, and Type 1 Diabetes (T1D). Dr. Cornea is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral required
Before you request

Children's Hospital At Erlanger Endocrinology

900 E 3rd St, 
Chattanooga, TN 
 (5.1 miles away)
423-778-5437
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexandra Martin is an Endocrinologist practicing medicine in Chattanooga, Tennessee. Dr. Martin is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Precocious Puberty, Thyroid Dysgenesis, Short Stature (Growth Disorders), and Vulvectomy. Dr. Martin is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral required
Before you request

Children's Hospital At Erlanger Endocrinology

900 E 3rd St, 
Chattanooga, TN 
 (5.1 miles away)
423-778-5437
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rita Shridharani is an Endocrinologist practicing medicine in Chattanooga, Tennessee. Dr. Shridharani is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Precocious Puberty, Short Stature (Growth Disorders), Idiopathic Short Stature (ISS), and Familial Short Stature (FSS). Dr. Shridharani is currently accepting new patients.

Frequently Asked Questions about Dr. David M. Huffman

How do I make an appointment with Dr. David M. Huffman?

You can book an appointment with Dr. David M. Huffman by calling their office at 423-265-3561. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David M. Huffman a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David M. Huffman is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David M. Huffman specialize in?

While Dr. David M. Huffman is a Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Hashimoto Thyroiditis, and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. David M. Huffman participate in research or clinical trials?

Yes. Dr. David M. Huffman has published 6 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. David M. Huffman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David M. Huffman accept my insurance?

Dr. David M. Huffman accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 423-265-3561 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Huffman's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile